![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
![[thumbnail of Supporting Information]](https://mdc-test.eprints-hosting.org/style/images/fileicons/other.png) |
Other (Supporting Information)
2MB |
| Item Type: | Article |
|---|---|
| Title: | Concomitant deletion of Ptpn6 and Ptpn11 in T cells fails to improve anticancer responses |
| Creators Name: | Ventura, P.M.O., Gakovic, M., Fischer, B.A., Spinelli, L., Rota, G., Pathak, S., Khameneh, H.J., Zenobi, A., Thomson, S., Birchmeier, W., Cantrell, D.A. and Guarda, G. |
| Abstract: | Anticancer T cells acquire a dysfunctional state characterized by poor effector function and expression of inhibitory receptors, such as PD-1. Blockade of PD-1 leads to T cell reinvigoration and is increasingly applied as an effective anticancer treatment. Recent work challenged the commonly held view that the phosphatase PTPN11 (known as SHP-2) is essential for PD-1 signaling in T cells, suggesting functional redundancy with the homologous phosphatase PTPN6 (SHP-1). Therefore, we investigated the effect of concomitant Ptpn6 and Ptpn11 deletion in T cells on their ability to mount antitumour responses. In vivo data show that neither sustained nor acute Ptpn6/11 deletion improves T cell-mediated tumor control. Sustained loss of Ptpn6/11 also impairs the therapeutic effects of anti-PD1 treatment. In vitro results show that Ptpn6/11-deleted CD8(+) T cells exhibit impaired expansion due to a survival defect and proteomics analyses reveal substantial alterations, including in apoptosis-related pathways. These data indicate that concomitant ablation of Ptpn6/11 in polyclonal T cells fails to improve their anticancer properties, implying that caution shall be taken when considering their inhibition for immunotherapeutic approaches. |
| Keywords: | PD-1 Checkpoint Blockade, Ptpn11, Ptpn6, T Cell Exhaustion, Animals, Mice |
| Source: | EMBO Reports |
| ISSN: | 1469-221X |
| Publisher: | EMBO Press / Wiley |
| Volume: | 23 |
| Number: | 11 |
| Page Range: | e55399 |
| Date: | 7 November 2022 |
| Official Publication: | https://doi.org/10.15252/embr.202255399 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
